Sharp Clinical Services to Attend the DIA 2014 50th Annual Meeting
Sharp Clinical Services, a Phoenixville, PA based solutions provider in the global pharmaceutical and biotechnology industries, will be exhibiting at the DIA 2014 50TH Annual Meeting, at the San Diego Convention Center, San Diego, CA starting June 15
The DIA 2014 50th Annual Meeting is perhaps the single largest event of a multidisciplinary nature to happen this year. A massive community of life sciences professionals across all levels and from all disciplines that are involved in the discovery, development, and life cycle management of medical technology and products gather at the meeting each year to discuss their common goals and how they can work together to achieve them.
The Annual Meeting is an incredibly important event in the industry because it not only allows industry professionals to network and create new professional relationships, but because it also fosters innovations that will eventually lead to the development of medical products and therapies for patients that are both safer and more effective than anything developed before.
The Annual Meeting is designed to provide this community of life science professionals with a global, unbiased platform from which to raise the level of discussion in order to facilitate innovations that will help shape the future of health care. It will also offer an integrated holistic approach to the development of regulated health care products' life cycle management.
Sharp Clinical Services will have several of their most important staff members attending the event. Vital personnel included in the company's roster for the event are John Phillips, Director, Sales & Marketing at Sharp Clinical Services, Nadine Duchateau, Director, Business Development, Midwest, Lindsay Haney, Director Business Development, West coast, and Michael McGloughlin, Director, Business Development, East coast.
According to Gregory Wojcik, the Associate Director of Business Operations and Marketing, "Sharp Clinical Services will show their presence in the Clinical Trial Supply arena as well as support the platforms of the DIA."